Can Autoimmunity Spark Alzheimer’s Disease?
Electronic health records show that various autoimmune disorders put people at higher risk for AD.
6586 RESULTS
Sort By:
Electronic health records show that various autoimmune disorders put people at higher risk for AD.
Triggered by senescent cells, macrophages spew a protease that dissolves junctions between the cells that separate CSF from blood.
In a mouse model of amyloidosis, the BACE1 enzyme snipped subunits of the GABA(A) receptor, squelching its inhibitory function.
Thinning out glycoproteins in the brain blood vessels of young mice allowed blood to leak into the brain. Promoting glycosylation in old mice strengthened the barrier.
In neurons, FAM171A2 opens the door to toxic fibrils. An approved cancer drug slams it shut.
The man has lots of plaques but few tangles 18 years after his expected age of onset; potential protective factors include extensive heat shock protein expression.
In neurons from a person with HD, knocking down MSH3 kept CAG nucleotide expansions from growing even longer.
The marker detected plaques and tangles with 90 percent accuracy in almost 200 autopsy-confirmed frontotemporal dementia cases.
Plasma Aβ42/40 ratios drop in people soon after COVID-19 infection even for mild cases. Does this mean they are at higher risk for dementia?
Amyloid and tau accumulation patterns differ in black, white, and Hispanic people.
At HAI, scientists report that tangle accumulation in tracts from the locus coeruleus keeps neural systems from communicating with one another when neurons die.
At Human Amyloid Imaging Conference, Plasma Tau Was the Star When Tau Wanders Off, Subcortical Axon Firing Goes Mum Studying Diverse Populations May Require New Biomarkers After 14 years in Miami, HAI is on the move again. This January conference started
In Puerto Rico, scientists agreed that jointly measuring multiple plasma tau markers could be a powerful readout of tau pathology in a person’s brain.
Scientists characterize early stage tau aggregates and develop a CSF test to track them.
In mice, this marker correlated better with amyloid protofibrils in the brain than with plaques. So did CSF markers of neurodegeneration, highlighting the toxicity of protofibrils.